BRISKEN LAB Hormones : Keys to Breast Cancer Prevention and Therapy
Selected Publications
Two-Tier Mapper, an unbiased topology-based clustering method for enhanced global gene expression analysis
Rachel Jeitziner – Bioinformatics 2019-02-07
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions
Maryse Fiche – The Journal of Pathology Dec 27 2018
A preclinical Model for ERa-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
George Sflomos – Cancer Cell, 14 March 2016
Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk
Renuga Devi Rajaram – EMBO Journal, 4 March 2015
Progesterone/RANKL is a Major Regulatory Axis in the Human Breast
Tamara Tanos – Science Translational Medecine, 24 April 2013
Adamts18 deletion results in distinct developmental defects and provides a model for congenital disorders of lens, lung, and female reproductive tract development
Dalya Ataca – Biology Open, 13 Sept. 2016
Contact
Head of laboratory
Prof. Cathrin Brisken
+41 21 693 0781
Administration
Magali Frainier
41 21 693 3461
Mailing Address:
EPFL SV ISREC UPBRI
SV 2832 (Building SV)
Station 19
CH-1015 Lausanne
Fax 41 21 693 0770